To date, pancreatic cancer is still one of the most lethal cancers in the world, mainly due to
the lack of early diagnosis and personalized treatment strategies. In this context, the …

Human pancreatic cancer has a very poor prognosis with an overall five-year survival rate of
less than 5% and an average median survival time of six months. This is largely due to …

Pancreatic cancer represents one of the most lethal disease worldwide but still orphan of a
molecularly driven therapeutic approach, although many genomic and transcriptomic …

Pancreatic ductal adenocarcinoma (referred here as pancreatic cancer) is a lethal disease
with the worst prognosis among all solid tumors. Surgical resection represents the only hope …

Pancreatic cancer (PC) is assumed to be an intimidating and deadly malignancy due to
being the leading cause of cancer-led mortality, predominantly affecting males of older age …

Simple Summary Based on the four molecular subtypes of pancreatic cancer described by
Bailey et al. 2016, in the present article we match the molecular, histology and …

Pancreatic cancer is a deadly disease with a dismal prognosis. However, recent advances
in sequencing and bioinformatic technology have led to the systematic characterization of …

Pancreatic cancer is a highly lethal tumor type for which there are few viable therapeutic
options. It is also caused by the accumulation of mutations in a variety of genes. These …

Background The 5-year survival rate of patients with pancreatic ductal adenocarcinoma
(PDAC) is around 5% due to the fact that the majority of patients present with advanced …

Introduction: Pancreatic adenocarcinoma remains one of the most clinically challenging
cancers despite an in-depth characterization of the molecular underpinnings and biology of …